These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32441805)

  • 1. Severe Acute Lung Injury Related to COVID-19 Infection: A Review and the Possible Role for Escin.
    Gallelli L; Zhang L; Wang T; Fu F
    J Clin Pharmacol; 2020 Jul; 60(7):815-825. PubMed ID: 32441805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutic targets for SARS-CoV-2-induced acute lung injury: Targeting a potential IL-1β/neutrophil extracellular traps feedback loop.
    Yaqinuddin A; Kashir J
    Med Hypotheses; 2020 Oct; 143():109906. PubMed ID: 32505910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2.
    Ma Q; Qiu M; Zhou H; Chen J; Yang X; Deng Z; Chen L; Zhou J; Liao Y; Chen Q; Zheng Q; Cai L; Shen L; Yang Z
    Pharmacol Res; 2020 Oct; 160():105073. PubMed ID: 32653650
    [No Abstract]   [Full Text] [Related]  

  • 4. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
    Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?
    Nasiripour S; Zamani F; Farasatinasab M
    J Clin Pharmacol; 2020 Jul; 60(7):828-829. PubMed ID: 32445400
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research.
    Bimonte S; Crispo A; Amore A; Celentano E; Cuomo A; Cascella M
    In Vivo; 2020 Jun; 34(3 Suppl):1597-1602. PubMed ID: 32503817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 and lung cancer: risks, mechanisms and treatment interactions.
    Addeo A; Obeid M; Friedlaender A
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32434788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides: Prospects for Use in the Treatment of COVID-19.
    Khavinson V; Linkova N; Dyatlova A; Kuznik B; Umnov R
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32987757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
    Lupu L; Palmer A; Huber-Lang M
    Front Immunol; 2020; 11():584514. PubMed ID: 33101314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Interleukin-6 in Lung Complications in Patients With COVID-19: Therapeutic Implications.
    Smetana K; Brábek J
    In Vivo; 2020 Jun; 34(3 Suppl):1589-1592. PubMed ID: 32503815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [COVID-19: a cardiological point-of-view].
    Weckbach LT; Kellnar A; Stremmel C; Stark K; Kääb S
    Dtsch Med Wochenschr; 2020 Jul; 145(15):1063-1067. PubMed ID: 32731280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment.
    Shah S; Danda D; Kavadichanda C; Das S; Adarsh MB; Negi VS
    Rheumatol Int; 2020 Oct; 40(10):1539-1554. PubMed ID: 32666137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboinflammation in COVID-19 acute lung injury.
    Mitchell WB
    Paediatr Respir Rev; 2020 Sep; 35():20-24. PubMed ID: 32653469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin manifestations associated with the new coronavirus SARS-CoV-2 disease.
    Redondo-Sendino Á; González Sánchez IC; de Victoria Fernández B
    Med Clin (Barc); 2020 Nov; 155(9):414-415. PubMed ID: 32873395
    [No Abstract]   [Full Text] [Related]  

  • 17. High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review : High levels of anti-SSA/Ro antibodies in COVID-19.
    Fujii H; Tsuji T; Yuba T; Tanaka S; Suga Y; Matsuyama A; Omura A; Shiotsu S; Takumi C; Ono S; Horiguchi M; Hiraoka N
    Clin Rheumatol; 2020 Nov; 39(11):3171-3175. PubMed ID: 32844364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic.
    Brufsky A
    J Med Virol; 2020 Jul; 92(7):770-775. PubMed ID: 32293710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactoferrin as potential preventative and adjunct treatment for COVID-19.
    Chang R; Ng TB; Sun WZ
    Int J Antimicrob Agents; 2020 Sep; 56(3):106118. PubMed ID: 32738305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19.
    Saul S; Einav S
    ACS Infect Dis; 2020 Sep; 6(9):2304-2318. PubMed ID: 32687696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.